English Polski

Wyszuk. zaawans.

Tom 19, Nr 1 (2022)
Artykuł przeglądowy
Opublikowany online: 2021-09-08
Dodaj do koszyka: 49,00 PLN
Wyświetlenia strony 7167
Wyświetlenia/pobrania artykułu 105
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Epidemiologia zaburzeń lękowych i depresyjnych

Bogumiła Lubecka1, Marek Lubecki1, Robert Pudlo1
DOI: 10.5603/PSYCH.a2021.0034
Psychiatria 2022;19(1):66-77.

Streszczenie

W artykule przedstawiono przegląd danych dotyczących częstości występowania zaburzeń lękowych i depresji u osób dorosłych. Prowadzenie badań epidemiologicznych dotyczących rozpowszechnienia zaburzeń lękowych i depresji w populacji ogólnej daje możliwość lepszego zrozumienia ich etiologii, oceny trendów zapadalności, identyfikacji czynników modyfikujących ryzyko oraz planowania działań profilaktycznych i strategii leczenia.

Słowa kluczowe: depresjazaburzenia lękoweepidemiologia.

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. World Health Organization (WHO). SpringerReference. .
    CrossRef
  2. Vos T, Allen C, Arora M et al. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545–1602.
    CrossRefPubMed
  3. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013; 34: 119–138.
    CrossRefPubMed
  4. Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011; 9: 90.
    CrossRefPubMed
  5. Malhi GS, Outhred T, Morris G, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary. Med J Aust. 2018; 208(4): 175–180.
    CrossRefPubMed
  6. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry. 1994; 55 Suppl(4): 5–10.
    PubMed
  7. Andrade L, Caraveo-Anduaga JJ, Berglund P, et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res. 2003; 12(1): 3–21.
    CrossRefPubMed
  8. Kessler R, Wittchen HU, Abelson J, et al. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US national comorbidity survey (NCS). International Journal of Methods in Psychiatric Research. 2006; 7(1): 33–55.
    CrossRef
  9. Kessler RC, Ustün TB, Demyttenaere K, et al. WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004; 291(21): 2581–2590.
    CrossRefPubMed
  10. Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety. 2010; 27(4): 351–364.
    CrossRefPubMed
  11. Klejna A, Piotrowski P, Adamowski T, et al. Rozpowszechnienie wybranych zaburzeń psychicznych w populacji dorosłych Polaków z odniesieniem do płci i struktury wieku - Badanie EZOP Polska. Psychiatr Pol. 2015; 49(1): 15S–27S.
  12. Badanie EZOP Polska. https://ezop.edu.pl/wp-content/uploads/2019/07/EZOP-I_Raport_max.pdf (24.04.2021).
  13. Van de Velde S, Bracke P, Levecque K. Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression. Soc Sci Med. 2010; 71(2): 305–313.
    CrossRefPubMed
  14. Hirschfeld RMA. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry. 2012; 73 Suppl 1: 5–9.
    CrossRefPubMed
  15. Tereszko A, Dudek D. Gender differences in mental disorders. Neuropsychiatria i Neuropsychologia. 2017; 12(4): 162–169.
    CrossRef
  16. Kessler RC, Berglund P, Demler O et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Arch Gen Psychiatry. 2005; 62: 593S–602S.
  17. Vilagut G, Forero CG, Barbaglia G, et al. Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis. PLoS One. 2016; 11(5): e0155431.
    CrossRefPubMed
  18. Babiarczyk B, Schlegel-Zawadzka M, Turbiarz A. Ocena częstości występowania objawów depresji w populacji osób powyżej 65. roku życia. Med Og Nauk Zdr. 2013; 19(4): 453S–457S.
  19. Mossakowska M, Więcek A, Błędowski P, et al. Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia się ludzie w Polsce. W: Broczek K., , Szybalska A. Występowanie objawów depresyjnych u osób starszych. Warszawa: Termedia Wydawnictwa Medyczne. ; 2012.
  20. Mamplekou E, Bountziouka V, Psaltopoulou T, et al. Urban environment, physical inactivity and unhealthy dietary habits correlate to depression among elderly living in eastern Mediterranean islands: the MEDIS (MEDiterranean ISlands Elderly) study. J Nutr Health Aging. 2010; 14(6): 449–455.
    CrossRefPubMed
  21. Chang-Quan H, Bi-Rong D, Hong-Mei Wu, et al. Depression and medical illness in chinese nonagenarians and centenarians. J Am Geriatr Soc. 2008; 56(12): 2359–2361.
    CrossRefPubMed
  22. Dobrzyńska E, Rymaszewska J, Kiejna A. Depresje u osób w wieku podeszłym. Psychogeriatr Pol. 2007; 4(1): 51S–60S.
  23. Humańska MA, Kędziora-Kornatowska K. Współzależność pomiędzy nasileniem stanów depresyjnych a poczuciem jakości życia u osób starszych. Psychogeriatr Pol. 2009; 6(1): 15S–22S.
  24. Kessler RC, Nelson CB, McGonagle KA, et al. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993; 29(2-3): 85–96.
    CrossRefPubMed
  25. Baxter AJ, Vos T, Scott KM, et al. The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. Int J Methods Psychiatr Res. 2014; 23(4): 422–438.
    CrossRefPubMed
  26. Baxter AJ, Scott KM, Vos T, et al. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013; 43(5): 897–910.
    CrossRefPubMed
  27. Wittchen HU, Lieb R, Schuster P, Oldehinkel AJ. When is onset? Investigations into early developmental stages of anxiety and depressive disorders. In J. L. Rapoport (Ed.), Childhood onset of adult psychopathology. Clinical and research advances. Washington, DC: American Psychiatric Press. 1999; 259S–302S.
  28. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011; 21(9): 655–679.
    CrossRefPubMed
  29. Forsell Y, Winblad B. Anxiety disorders in non-demented and demented elderly patients: prevalence and correlates. J Neurol Neurosurg Psychiatry. 1997; 62(3): 294–295.
    CrossRefPubMed
  30. Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry. 2004; 184: 147–152.
    CrossRefPubMed
  31. Schaub RT, Linden M. Anxiety and anxiety disorders in the old and very old--results from the Berlin Aging Study (BASE). Compr Psychiatry. 2000; 41(2 Suppl 1): 48–54.
    CrossRefPubMed
  32. Gustavsson A, Svensson M, Jacobi F, et al. CDBE2010Study Group. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011; 21(9): 655–679.
    CrossRefPubMed
  33. Wiltink J, Beutel ME, Till Y, et al. Prevalence of distress, comorbid conditions and well being in the general population. J Affect Disord. 2011; 130(3): 429–437.
    CrossRefPubMed
  34. Christiana JM, Gilman SE, Guardino M, et al. Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med. 2000; 30(3): 693–703.
    CrossRefPubMed
  35. Kendall PC, Kessler RC. The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations. J Consult Clin Psychol. 2002; 70(6): 1303–1306.
    PubMed
  36. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 67(3): 363–374.
    CrossRefPubMed
  37. Goodwin RD, Faravelli C, Rosi S, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005; 15(4): 435–443.
    CrossRefPubMed
  38. Balaram K., Marwaha R. Agoraphobia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 Jan. https://www.ncbi.nlm.nih.gov/books/NBK554387/ (01.03.2021).
  39. Roest A, Vries Y, Lim C, et al. A comparison of DSM ‐5 and DSM ‐IV agoraphobia in the World Mental Health Surveys. Depression and Anxiety. 2019; 36(6): 499–510.
    CrossRef
  40. Sigström R, Skoog I, Karlsson B, et al. NINE-YEAR FOLLOW-UP OF SPECIFIC PHOBIA IN A POPULATION SAMPLE OF OLDER PEOPLE. Depress Anxiety. 2016; 33(4): 339–346.
    CrossRefPubMed
  41. Wells JE, Browne MA, Scott KM, et al. New Zealand Mental Health Survey Research Team. Prevalence, interference with life and severity of 12 month DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry. 2006; 40(10): 845–854.
    CrossRefPubMed
  42. Gum AM, King-Kallimanis B, Kohn R. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry. 2009; 17(9): 769–781.
    CrossRefPubMed
  43. Grenier S, Schuurmans J, Goldfarb M, et al. Scientific committee of the ESA study. The epidemiology of specific phobia and subthreshold fear subtypes in a community-based sample of older adults. Depress Anxiety. 2011; 28(6): 456–463.
    CrossRefPubMed
  44. LeBeau RT, Glenn D, Liao B, et al. Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Depress Anxiety. 2010; 27(2): 148–167.
    CrossRefPubMed
  45. Wardenaar KJ, Lim C, Al-Hamzawi AO, et al. The cross-national epidemiology of specific phobia in the World Mental Health Surveys. Psychological Medicine. 2017; 47(10): 1744–1760.
    CrossRef
  46. Burstein M, Georgiades K, He JP, et al. Specific phobia among U.S. adolescents: phenomenology and typology. Depress Anxiety. 2012; 29(12): 1072–1082.
    CrossRefPubMed
  47. Alonso J, Angermeyer MC, Bernert S, et al. ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project, ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004(420): 8–20.
    CrossRefPubMed
  48. DeWit DJ, Ogborne A, Offord DR, et al. Antecedents of the risk of recovery from DSM-III-R social phobia. Psychol Med. 1999; 29(3): 569–582.
    CrossRefPubMed
  49. Stein D, Lim C, Roest A, et al. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Medicine. 2017; 15(1).
    CrossRef
  50. Hoyer J, Beesdo K, Bittner A, Wittchen HU. Epidemiology of anxiety disorders. In A. C. Altamura (Ed.), Comorbidity of generalized anxiety disorder and mood disorders. 2003; pp. 44S–83S.
  51. Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch Gen Psychiatry. 1998; 55(11): 1017–1024.
    CrossRefPubMed
  52. Rouillon F, Rouillon F. [Panic disorder in general medicine. Epidemiological data and treatment with clomipramine]. Encephale. 1988; 14(5): 371–378.
    PubMed
  53. Skapinakis P, Lewis G, Davies S, et al. Panic disorder and subthreshold panic in the UK general population: epidemiology, comorbidity and functional limitation. Eur Psychiatry. 2011; 26(6): 354–362.
    CrossRefPubMed
  54. Goodwin RD, Faravelli C, Rosi S, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005; 15(4): 435–443.
    CrossRefPubMed
  55. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 67(3): 363–374.
    CrossRefPubMed
  56. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006; 63(4): 415–424.
    CrossRefPubMed
  57. Batelaan N, De Graaf R, Van Balkom A, et al. Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med. 2007; 37(2): 247–256.
    CrossRefPubMed
  58. Goodwin RD, Faravelli C, Rosi S, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005; 15(4): 435–443.
    CrossRefPubMed
  59. Kojima M, Shioiri T. xxxxxxxxxxxxxxxxxxxxxxxxx. In: Higuchi T, Kuboki T, Nakamura J, Yamawaki S. ed. Panic disorder stress navigator. wyd xxxxxxxxxxxxxxx, xxxxxxxxxxx 2004: 20–1.
  60. de Jonge P, Roest AM, Lim CCW, et al. Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depress Anxiety. 2016; 33(12): 1155–1177.
    CrossRefPubMed
  61. Kessler RC, Stang PE, Wittchen HU, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry. 1998; 55(9): 801–808.
    CrossRefPubMed
  62. Corominas A, Guerrero T, Vallejo J. Residual symptoms and comorbidity in panic disorder. Eur Psychiatry. 2002; 17(7): 399–406.
    CrossRefPubMed
  63. Tsao J, Lewin M, Craske M. The Effects of Cognitive-Behavior Therapy for Panic Disorder on Comorbid Conditions. Journal of Anxiety Disorders. 1998; 12(4): 357–371.
    CrossRef
  64. Craske MG, Kircanski K, Epstein A, et al. DSM V Anxiety, OC Spectrum, Posttraumatic and Dissociative Disorder Work Group. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V. Depress Anxiety. 2010; 27(2): 93–112.
    CrossRefPubMed
  65. Kessler RC, Brandenburg N, Lane M, et al. Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med. 2005; 35(7): 1073–1082.
    CrossRefPubMed
  66. Ruscio AM, Hallion LS, Lim CCW, et al. Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe. JAMA Psychiatry. 2017; 74(5): 465–475.
    CrossRefPubMed
  67. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(3): 327–337.
    CrossRefPubMed
  68. Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15(1): 53–63.
    CrossRefPubMed
  69. Fullana MA, Vilagut G, Rojas-Farreras S, et al. ESEMeD/MHEDEA 2000 investigators. Obsessive-compulsive symptom dimensions in the general population: results from an epidemiological study in six European countries. J Affect Disord. 2010; 124(3): 291–299.
    CrossRefPubMed
  70. Stein D. Obsessive-compulsive disorder. The Lancet. 2002; 360(9330): 397–405.
    CrossRef
  71. Hollander E, Stein DJ. Obsessive-compulsive disorders. Diagnosis. Etiology. Treatment. Marcel Dekker, New York 1997.
  72. Weismann MM, Bland RC, Canino GJ et al. The cross national epidemiology of obsessive-compulsive disorder. The Cross National Collaborative Study. J. Clin. Psychiatry. 1994; 55: 103S–111S. 1994.
  73. Krzanowska E, Kuleta M. From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11. Archives of Psychiatry and Psychotherapy. 2017; 19(3): 7–15.
    CrossRef
  74. Breslau N, Kessler RC, Chilcoat HD, et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998; 55(7): 626–632.
    CrossRefPubMed
  75. Salyers MP, Evans LJ, Bond GR, et al. Barriers to assessment and treatment of posttraumatic stress disorder and other trauma-related problems in people with severe mental illness: clinician perspectives. Community Ment Health J. 2004; 40(1): 17–31.
    CrossRefPubMed
  76. DiMaggio C, Galea S. The behavioral consequences of terrorism: a meta-analysis. Acad Emerg Med. 2006; 13(5): 559–566.
    CrossRefPubMed
  77. Neria Y, Nandi A, Galea S, et al. The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev. 2005; 27(4): 78–91.
    CrossRefPubMed
  78. Kessler RC, Üstün TB. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. Cambridge University Press, New York 2008: 1–580.
  79. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6): 617–627.
    CrossRefPubMed

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

Copyright © 2023-2024 Via Medica Regulamin Polityka cookies Polityka prywatności Nota prawna